FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS
Clinical trials for FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS trials appear
Sign up with your email to follow new studies for FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could help teens with inherited high cholesterol
Disease control CompletedThis study tested a drug called inclisiran in teenagers aged 12 to 18 who have a genetic condition that causes very high cholesterol. The goal was to see if the drug is safe and can lower bad cholesterol. Participants received either inclisiran or a placebo for one year, then eve…
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Heart attack patients under 60 get genetic screening for hidden cholesterol disorder
Diagnosis CompletedThis study tested whether offering genetic screening to younger heart attack patients (under 60) can uncover hidden cases of Familial Hypercholesterolemia (FH), an inherited condition causing very high cholesterol. Researchers recruited 140 patients admitted with a heart attack a…
Matched conditions: FAMILIAL HYPERCHOLESTEROLEMIA - HETEROZYGOUS
Phase: NA • Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC